Esther Sanfeliu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Childhood Cancer

Placebo Controlled

Top Venues

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriela Oses, Eduard Mension Coll, Claudia Pumarola, Helena Castillo, León Francesc, Inés Torras, Isaac Cebrecos, Xavier Caparrós, Sergi Ganau, Belén Ubeda, Xavier Bargallo, Blanca González, Esther Sanfeliu, Sergi Vidal-Sicart, Reinaldo Moreno, Montserrat Muñoz, Gorane Santamaría, Meritxell Molla
Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram. Cancers 15 (8) (2023)
Gabriela Oses, Eduard Mension Coll, Claudia Pumarola, Helena Castillo, León Francesc, Inés Torras, Isaac Cebrecos, Xavier Caparrós, Sergi Ganau, Belén Ubeda, Xavier Bargallo, Blanca González, Esther Sanfeliu, Sergi Vidal-Sicart, Reinaldo Moreno, Montserrat Muñoz, Gorane Santamaría, Meritxell Molla
Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram. Cancers 15 (8) (2023)
Aleix Prat, Luis G Paz-Ares, Manel Juan, Enriqueta Felip Font, Elena Garralda, Blanca Gonzalez-Farre, Ana M Arance, Juan Martín-Liberal, Joaquín Gavilá, Ana López-González, Juan Miguel Cejalvo, Yann Izarzugaza, Kepa Amillano, Javier García Corbacho, Cristina Saura, Fabricio Racca, Cinta Hierro, Esther Sanfeliu, Xavier Gonzalez, Jordi Canes, Guillermo Villacampa, Fernando Salvador, Tomás Pascual, Ricard Mesía, Andres Cervantes, Josep Tabernero
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA. Future oncology (London, England) (2022)